Invokana 100 mg and 300mg film coated tablets

*
Pharmacy Only: Prescription

Updated on 16 October 2024

File name

Invokana-SmPC-clean-IE Approved Sept 24.pdf

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 5.3 - Preclinical safety data

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 16 October 2024

File name

Invokana-PIL-clean-UKNI & IE Approved Sept 24.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions

Free text change information supplied by the pharmaceutical company

Warning and precautions updated regarding upcoming surgeries / procedures

Updated on 28 June 2023

File name

IE-Invokana-Approved -June 2023-SmPC-clean.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction

Legal category:Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Section 4.4 - Diabetic ketoacidosis added

Section 4.5 - Lithium added


Updated on 28 June 2023

File name

NI & IE-Invokana-Approved-June 2023-PIL-clean.pdf

Reasons for updating

  • Change to section 2 - interactions with other medicines, food or drink

Free text change information supplied by the pharmaceutical company

Section 2 - interactions with Lithium added

Updated on 15 June 2023

File name

Invokana SmpC Approved feb 23.pdf

Reasons for updating

  • Previous version of SPC reinstated

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 13 June 2023

File name

Invokana SmpC Approved May 23 - Article 61-3 IE details.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 13 June 2023

File name

Invokana-PIL-clean Approved May 23.pdf

Reasons for updating

  • New PIL for new product